Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous CIK Cells for HCC After Local Therapy
NCT03124498Phase 2Unknown
- Sponsor
- Chuan An Biotechnology
- Start
- Nov 2017
- Primary completion
- Jun 2019
- Modality
- Prophylactic Vaccines, Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs)
01
Overview
A Phase 2 trial of autologous cytokine-induced killer cells in hepatocellular carcinoma (HCC), sponsored by Chuan An Biotechnology. Status: unknown.
02
Drugs
autologous cytokine-induced killer cells
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03124498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03124498.